Increasing Body Mass Index Tied to 18 Site-Specific Cancers in Men
By Lori Solomon HealthDay Reporter
WEDNESDAY, Dec. 13, 2023 -- Increasing body mass index (BMI) at age 18 years is associated with development of subsequent site-specific cancers in men, according to a study published online Nov. 6 in Obesity.
Aron Onerup, M.D., Ph.D., from the University of Gothenburg in Sweden, and colleagues examined BMI at age 18 years and incident site-specific cancer (malignant melanoma; leukemia; myeloma; Hodgkin lymphoma; non-Hodgkin lymphoma; and cancer in the lungs, head and neck, central nervous system, thyroid, esophagus, stomach, pancreas, liver and gallbladder, colon, rectum, kidney, and bladder) to estimate population attributable fractions due to BMI based on projected obesity prevalence. The analysis included 1.5 million men.
The researchers found that 78,217 men subsequently developed cancer during a mean 31 years of follow-up. There was a linear association between BMI and the risk for developing all 18 site-specific cancers assessed. In some instances, there was an association even with BMI levels usually defined as normal (20 to 25 kg/m2). For prostate cancer, there was an inverse association observed, with higher BMI associated with lower risk. Gastrointestinal cancers had the highest hazard ratios and population attributable fractions.
"If current obesity trends continue, our findings provide additional support for rapid action to stem the course of the obesity epidemic and, with a large prevalence of youth overweight and obesity already in existence, to prepare the health care system for a steeply increasing number of cancer cases,” the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Recommendations Issued for Palliative RT for Symptomatic Bone Mets
THURSDAY, May 30, 2024 -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published online May 22 in Practical Radiation Oncology...
Demographic, Clinical, Financial Factors Tied to GLP-1 Agonist Discontinuation
WEDNESDAY, May 29, 2024 -- Specific demographic, clinical, and financial characteristics are associated with glucagon-like peptide 1 (GLP-1) receptor agonist discontinuation...
Living Outside of Comprehensive Cancer Center Catchment Area Tied to Later-Stage Diagnosis
TUESDAY, May 28, 2024 -- Disadvantaged populations and those living outside of a comprehensive cancer center's main catchment area have higher odds of receiving a diagnosis of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.